Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2015-02-03 Proxy Solicitation & In…
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Notice of EGM and sample form of proxy 19 pages 788.1KB
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an ASX announcement dated 4 February 2015, titled 'Notice of Extraordinary General Meeting and Sample Proxy' for Genetic Technologies Limited. It includes detailed information about the upcoming Extraordinary General Meeting (EGM) scheduled for 6 March 2015, including resolutions to be voted on, proxy appointment instructions, voting entitlement, and explanatory notes about capital raising activities and share placements. The content focuses on notifying shareholders about the meeting, the agenda, and voting procedures rather than presenting financial results or management discussion. The document is lengthy (15,000 characters) and contains the full notice and proxy form, which are typical for meeting notices. This fits the category of Proxy Solicitation & Information Statement (PSI), as it is material sent to shareholders to provide information and request votes for the meeting. It is not an announcement of voting results (DVA), nor a capital/financing update (CAP) since it is about the meeting notice and proxy, not a standalone capital update. Therefore, the correct classification is PSI with high confidence.
2015-02-03 English
Appendix 3B - 2 February 2015 12 pages 550.1KB
Regulatory Filings
2015-02-01 English
Appendix 3B - 30 January 2015 12 pages 263.4KB
Regulatory Filings
2015-01-29 English
Quarterly Activities Report - 31 December 2014 12 pages 3.4MB
Regulatory Filings
2015-01-29 English
New Centre Adoption 2 pages 141.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 29 January 2015 from Genetic Technologies Limited. It discusses the launch and expected sales growth of a product called BREVAGen plus, including marketing strategy and target customers. There are no financial statements, no detailed financial performance data, no regulatory filings or certifications, and no mention of shareholder votes or management changes. The document is a corporate announcement about product and sales updates rather than a financial report or regulatory filing. It is not a report publication announcement since it does not mention any report being attached or published. Therefore, the best fitting category is a general Regulatory Filing (RNS) as a miscellaneous corporate announcement that does not fit other specific categories.
2015-01-28 English
Tribute to Mr David Carter 2 pages 140.3KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 29 January 2015, expressing a tribute to Mr. David Carter, a person associated with the company. It contains no financial data, no report or results, no regulatory filings, no voting results, no management changes, no capital updates, and no other typical financial or corporate filing content. The document is short (4047 characters) and is a public announcement of a non-financial nature. It does not fit into any specific financial report or regulatory filing category. Therefore, the best classification is Regulatory Filings (RNS) as a general announcement that does not fit other categories.
2015-01-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.